Recent Updates
Recently added Catalysts
ATEC Positive Sentiment

ATEC Reports Third Quarter Financial Results

Thursday, October 29, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Alphatec Holdings, Inc. reported its financial results for the third quarter of 2026, revealing total revenue of $221 million. The company achieved a GAAP gross margin of 71.5% and a non-GAAP gross margin of 71.9%. Operating expenses were reported at $155 million, reflecting the company's ongoing investment in its spine surgery solutions.

Market Sentiment Analysis

POSITIVE FACTORS

  • Total revenue reached $221 million.
  • GAAP gross margin improved to 71.5%.
  • Non-GAAP gross margin was 71.9%.

Full Press Release Details

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended September 30, 2026, and business highlights. Third Quarter 2026 Financial Results   Quarter Ended September 30, 2026 Total revenue $221 million GAAP gross margin 71.5% Non-GAAP gross margin 71.9% GAAP operating expenses $155 million Non-GAAP operating expense

Frequently Asked Questions

What was Alphatec's total revenue for Q3 2026?

Alphatec reported total revenue of $221 million for Q3 2026.

What was the GAAP gross margin for ATEC?

The GAAP gross margin for Alphatec was 71.5%.

How much were Alphatec's operating expenses?

Alphatec's operating expenses were reported at $155 million.

What is the non-GAAP gross margin for ATEC?

The non-GAAP gross margin for Alphatec was 71.9%.

ShareAdd on Google
Tags: ATEC Alphatec spine surgery financial results Q3 2026
Last updated: Oct 29, 2026

Biotech snapshot

Cash runway
$119M liquidity · $0M/mo burn
Low dilution risk